Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Phase II data for PF-04457845 as potential treatment of cannabis withdrawal and dependence

Jan. 15, 2019

Nanoscavenger versus neurotoxins

Jan. 7, 2019

ITI-333 shows promise for the treatment of pain and substance abuse-derived disorders

Dec. 24, 2018

Adial engages CRO to oversee phase III trial of AD-04 for alcohol use disorder

Nov. 23, 2018

Weekly and monthly Buvidal approved in Europe for opioid dependence

Nov. 23, 2018

Blocking BigLEN-GRP171 signaling reduces opioid addiction and withdrawal in mice

Nov. 15, 2018

KemPharm adds drug for stimulant use disorder to pipeline

Nov. 15, 2018

TMPRSS11E gene identified as a novel biomarker of smoking-related traits in Europeans

Oct. 30, 2018

France becomes first country to market baclofen preparation to reduce alcohol consumption

Oct. 29, 2018

Enzyme instead of antibody to kick smoking habit?

Oct. 23, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...